The safety and clinical benefit of budesonide/formoterol pressurized metered-dose inhaler versus budesonide alone in children.

@article{Berger2010TheSA,
  title={The safety and clinical benefit of budesonide/formoterol pressurized metered-dose inhaler versus budesonide alone in children.},
  author={William E Berger and Jeffrey G Leflein and David E. Geller and Bhash M Parasuraman and Christopher J Miller and C. Douglas O'Brien and Liza C O'Dowd},
  journal={Allergy and asthma proceedings},
  year={2010},
  volume={31 1},
  pages={26-39}
}
Few studies have evaluated inhaled corticosteroid (ICS)/long-acting beta(2)-adrenergic agonist combination therapy in asthmatic children. This study was designed to evaluate the safety (primary) and clinical benefits (secondary) of budesonide/formoterol pressurized metered-dose inhaler (pMDI) versus budesonide dry powder inhaler (DPI) in children with persistent asthma. This was a 26-week, multicenter, randomized, open-label U.S. study of 187 children 6-11 years of age previously receiving ICS… CONTINUE READING
9 Citations
34 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 34 references

and Drug Administration

  • U. S. Foo
  • Summary Minutes of the Joint Pulmonary-Allergy…
  • 2009
1 Excerpt

Similar Papers

Loading similar papers…